GTG.AX - Genetic Technologies Limited

ASX - ASX Delayed price. Currency in AUD
0.0090
0.0000 (0.00%)
At close: 3:28PM AEDT
Stock chart is not supported by your current browser
Previous close0.0090
Open0.0090
Bid0.008 x 0
Ask0.009 x 0
Day's range0.0080 - 0.0090
52-week range0.0060 - 0.0170
Volume2,534,000
Avg. volume2,982,025
Market cap23.797M
Beta (3Y monthly)2.42
PE ratio (TTM)N/A
EPS (TTM)-0.002
Earnings date1 Mar. 2016 - 5 Mar. 2016
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est0.25
  • GlobeNewswire21 days ago

    Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres

    MELBOURNE, Australia, Feb. 01, 2019 -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company is pleased to announce the.

  • GlobeNewswire2 months ago

    Genetic Technologies Limited Provides End of Year Update on the Test Development Program

    Genetic Technologies Limited (ASX:GTG) (GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, provides today an update on its R&D program for the year. As announced to the market on 16th March 2018, Genetic Technologies Limited has embarked on a collaborative research program with academic research staff from the Centre for Epidemiology and Biostatistics at The University of Melbourne. Led by Professor John Hopper, the research is designed to broaden the applicability of the BREVAGenplus® breast cancer risk assessment test enabling its use in women with an extended family history of disease and will also increase the range of risk factors analysed.

  • GlobeNewswire2 months ago

    Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture

    MELBOURNE, Australia, Dec. 20, 2018 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), via its subsidiary Gene Ventures Pty Ltd, is pleased to announce that.

  • Genetic Technologies Stock Up on Genetic Test Update
    Market Realist7 months ago

    Genetic Technologies Stock Up on Genetic Test Update

    Today, Genetic Technologies (GENE) was trading over 70% higher than yesterday’s closing price of $1.09. The stock jumped ~72.5% in premarket trading. The stock price and volumes rose on the news of the company’s on-track breast cancer and colorectal cancer risk assessment tests, slated for release in October.